Independent Financial Group LLC Acquires Shares of 2,597 Tenet Healthcare Corporation $THC

Independent Financial Group LLC bought a new position in shares of Tenet Healthcare Corporation (NYSE:THC) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,597 shares of the company’s stock, valued at approximately $490,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Triumph Capital Management purchased a new position in shares of Tenet Healthcare in the 3rd quarter valued at $25,000. Activest Wealth Management acquired a new position in Tenet Healthcare in the fourth quarter valued at $26,000. Elyxium Wealth LLC acquired a new stake in shares of Tenet Healthcare during the fourth quarter worth about $29,000. Canada Pension Plan Investment Board purchased a new stake in shares of Tenet Healthcare in the 2nd quarter valued at about $35,000. Finally, Meeder Asset Management Inc. grew its stake in Tenet Healthcare by 146.2% during the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after buying an additional 114 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Price Performance

Shares of NYSE:THC opened at $199.85 on Friday. The firm has a market capitalization of $17.22 billion, a price-to-earnings ratio of 10.39, a price-to-earnings-growth ratio of 1.62 and a beta of 1.27. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The business’s 50 day simple moving average is $184.43 and its 200-day simple moving average is $197.37. Tenet Healthcare Corporation has a 12 month low of $146.60 and a 12 month high of $247.21.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Friday, July 24th. The company reported $6.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The company had revenue of $5.63 billion during the quarter, compared to analysts’ expectations of $5.43 billion. During the same quarter in the previous year, the business posted $4.02 earnings per share. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, equities analysts forecast that Tenet Healthcare Corporation will post 17.5 earnings per share for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In other news, Director J Robert Kerrey sold 5,638 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the sale, the director owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total transaction of $532,050.00. Following the transaction, the director directly owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. This represents a 10.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.97% of the stock is currently owned by corporate insiders.

Key Headlines Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported second-quarter EPS of $6.12, well above consensus, and revenue of $5.63 billion, also topping estimates, signaling stronger-than-expected operating performance. Article Title
• Positive Sentiment: The company raised FY 2026 guidance to EPS of $20.30-$21.69, above Wall Street expectations, which suggests management sees continued earnings strength ahead. Article Title
• Positive Sentiment: Investor optimism was also supported by Tenet’s improving credit profile and recent analyst sentiment, which had already set up the stock for a strong move into earnings. Article Title
• Neutral Sentiment: Analysts continue to view the stock favorably overall, with a consensus “Moderate Buy” rating, though some recent commentary has been more cautious on valuation. Article Title

Wall Street Analysts Forecast Growth

THC has been the topic of a number of recent research reports. Weiss Ratings cut shares of Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 2nd. Guggenheim lowered their price target on Tenet Healthcare from $252.00 to $242.00 and set a “buy” rating on the stock in a report on Monday. Robert W. Baird reduced their price objective on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a research note on Tuesday, May 5th. Stephens lowered their target price on Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Finally, Morgan Stanley set a $254.00 target price on Tenet Healthcare in a report on Friday, May 1st. Seventeen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $244.84.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.